37 related articles for article (PubMed ID: 8133717)
1. Ciprofloxacin versus colistin prophylaxis during neutropenia in acute myeloid leukemia: two parallel patient cohorts treated in a single center.
Pohlen M; Marx J; Mellmann A; Becker K; Mesters RM; Mikesch JH; Schliemann C; Lenz G; Müller-Tidow C; Büchner T; Krug U; Stelljes M; Karch H; Peters G; Gerth HU; Görlich D; Berdel WE
Haematologica; 2016 Oct; 101(10):1208-1215. PubMed ID: 27470601
[TBL] [Abstract][Full Text] [Related]
2. Feasibility, efficacy, and adverse effects of outpatient antibacterial prophylaxis in children with acute myeloid leukemia.
Inaba H; Gaur AH; Cao X; Flynn PM; Pounds SB; Avutu V; Marszal LN; Howard SC; Pui CH; Ribeiro RC; Hayden RT; Rubnitz JE
Cancer; 2014 Jul; 120(13):1985-92. PubMed ID: 24677028
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxis.
De Rosa FG; Motta I; Audisio E; Frairia C; Busca A; Di Perri G; Marmont F
BMC Infect Dis; 2013 Dec; 13():563. PubMed ID: 24289496
[TBL] [Abstract][Full Text] [Related]
4. Ciprofloxacin prophylaxis in high risk neutropenic patients: effects on outcomes, antimicrobial therapy and resistance.
Garnica M; Nouér SA; Pellegrino FL; Moreira BM; Maiolino A; Nucci M
BMC Infect Dis; 2013 Jul; 13():356. PubMed ID: 23899356
[TBL] [Abstract][Full Text] [Related]
5. FOVOCIP study: a multicenter randomized trial of fosfomycin versus ciprofloxacin for febrile neutropenia in hematologic patients-efficacy and microbiologic safety.
Moreno AF; Lavín-Alconero L; de Ugarriza PL; Blanco LS; Hernández SC; Burgués JMB; de Miguel MI; Huerta AJG; Zarzuela MP; Boluda B; Humala K; Calabuig ML; Amigo ML; Casas MC; Del Mar García-Saiz M; Verdugo AF; Domínguez JF; Bernal T
Trials; 2023 Oct; 24(1):694. PubMed ID: 37891616
[TBL] [Abstract][Full Text] [Related]
6. Secondary infections in cancer patients with febrile neutropenia.
Azap A; Bozkurt GY; Yüksel MK; Kutlu H; Topçuoğlu P; Aypak A; Akan H
Turk J Haematol; 2012 Sep; 29(3):254-8. PubMed ID: 24744669
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial prophylaxis in pediatric patients with leukemia.
Al Omar S; Moumani D; Rihani R
Saudi Pharm J; 2018 Sep; 26(6):810-816. PubMed ID: 30202221
[TBL] [Abstract][Full Text] [Related]
8. Infection-related mortality and infection control practices in childhood acute myeloid leukemia in a limited resource setting: Experience with the Indonesian national protocol.
Supriyadi E; Purwanto I; Widiastuti Z; Armytasari I; Sandi S; Ardianto B; Kaspers GJL
Belitung Nurs J; 2024; 10(2):185-191. PubMed ID: 38690309
[TBL] [Abstract][Full Text] [Related]
9. The role of prophylaxis of bacterial infections in children with acute leukemia/non-hodgkin lymphoma.
Castagnola E
Pediatr Rep; 2014 May; 6(2):5332. PubMed ID: 24987511
[TBL] [Abstract][Full Text] [Related]
10. Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia.
Kern WV; Klose K; Jellen-Ritter AS; Oethinger M; Bohnert J; Kern P; Reuter S; von Baum H; Marre R
Eur J Clin Microbiol Infect Dis; 2005 Feb; 24(2):111-8. PubMed ID: 15714332
[TBL] [Abstract][Full Text] [Related]
11. Prevention of bacterial infection in neutropenic patients with hematologic malignancies. A randomized, multicenter trial comparing norfloxacin with ciprofloxacin. The GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
Ann Intern Med; 1991 Jul; 115(1):7-12. PubMed ID: 2048868
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisions.
Leibovici L; Paul M; Cullen M; Bucaneve G; Gafter-Gvili A; Fraser A; Kern WV
Cancer; 2006 Oct; 107(8):1743-51. PubMed ID: 16977651
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial of continuous infusion versus bolus mitoxantrone in combination with cytarabine in newly diagnosed patients with acute myeloblastic leukemia.
Koc Y; Oyan B; Kars A; Tekuzman G; Canpinar H; Kansu E
Hematol Oncol; 2004 Jun; 22(2):43-53. PubMed ID: 15386563
[TBL] [Abstract][Full Text] [Related]
14. [Prophylaxis with ciprofloxacin in postchemotherapy neutropenia in acute myeloid leukemia].
López A; Soler JA; Juliá A; Novo A; Bueno J
Med Clin (Barc); 1994 Jan; 102(3):81-5. PubMed ID: 8133717
[TBL] [Abstract][Full Text] [Related]
15. [Fluoroquinolone prophylaxis utility during chemotherapy-induced severe neutropenia in patients with acute leukemia, with fluoroquinolone resistance high prevalence, in a reference hospital in Mexico City].
Ugarte-Torres A; Villasis-Keever A; Hernández-Bribiesca ME; Crespo-Solis E; Ruiz-Palacios GM; Sifuentes-Osornio J; Ponce-De-León-Garduño A
Rev Invest Clin; 2006; 58(6):547-54. PubMed ID: 17432285
[TBL] [Abstract][Full Text] [Related]
16. Ciprofloxacin prophylaxis in patients with acute leukemia and granulocytopenia in an area with a high prevalence of ciprofloxacin-resistant Escherichia coli.
Gomez L; Garau J; Estrada C; Marquez M; Dalmau D; Xercavins M; Martí JM; Estany C
Cancer; 2003 Jan; 97(2):419-24. PubMed ID: 12518366
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
